Outpatient chemotherapy: hospital-level, risk-adjusted rates of inpatient admissions or ED visits for cancer patients greater than or equal to 18 years of age for at least one of the following ten diagnoses—anemia, dehydration, diarrhea, emesis, fever, nausea, neutropenia, pain, pneumonia, or sepsis—within 30 days of hospital-based outpatient chemotherapy treatment.
- Published By Centers for Medicare & Medicaid Services
- Measurement Settings Emergency Department, Hospital Inpatient, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Excess days in acute care (EDAC): hospital-level, 30-day risk-standardized EDAC following heart failure (HF).
- Published By Centers for Medicare & Medicaid Services, Yale-New Haven Health Services Corporation/Center for Outcomes Research and Evaluation under contract to Centers for Medicare & Medicaid Services
- Measurement Settings Hospital Inpatient
- Professionals Involved In the Delivery of Service
Excess days in acute care (EDAC): hospital-level, 30-day risk-standardized EDAC following acute myocardial infarction (AMI).
- Published By Centers for Medicare & Medicaid Services, Yale-New Haven Health Services Corporation/Center for Outcomes Research and Evaluation under contract to Centers for Medicare & Medicaid Services
- Measurement Settings Hospital Inpatient
- Professionals Involved In the Delivery of Service
Total hip arthroplasty (THA) and/or total knee arthroplasty (TKA): hospital-level, risk-standardized payment associated with a 90-day episode of care for elective primary THA and/or TKA.
- Published By Centers for Medicare & Medicaid Services, Yale-New Haven Health Services Corporation/Center for Outcomes Research and Evaluation under contract to Centers for Medicare & Medicaid Services
- Measurement Settings Hospital Inpatient
- Professionals Involved In the Delivery of Service
Hospital inpatients' experiences: percentage of adult inpatients who reported they understood their care when they left the hospital.
- Published By Agency for Healthcare Research and Quality, CAHPS Consortium, Centers for Medicare & Medicaid Services
- Measurement Settings Hospital Inpatient, Transition
- Professionals Involved In the Delivery of Service
Colorectal cancer: proportion of patients between 50 and 74 years of age at diagnosis with Dukes C, or high risk Dukes B, colorectal cancer who undergo surgical resection who receive adjuvant chemotherapy.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory/Office-based Care, Ambulatory Procedure/Imaging Center, Hospital Inpatient, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Colorectal cancer: proportion of patients with colorectal cancer who die within 30 or 90 days of emergency or elective surgical resection.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Hospital Inpatient
- Professionals Involved In the Delivery of Service
Colorectal cancer: proportion of patients with rectal cancer who undergo a surgical procedure involving anastomosis of the rectum (including anterior resection with total mesorectal excision ) having anastomotic leak requiring intervention (radiological or surgical).
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Hospital Inpatient
- Professionals Involved In the Delivery of Service
Colorectal cancer: proportion of patients with colorectal cancer who undergo a surgical procedure involving anastomosis of the colon having anastomotic leak requiring intervention (radiological or surgical).
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Hospital Inpatient
- Professionals Involved In the Delivery of Service
Colorectal cancer: proportion of patients who undergo surgical resection for colorectal cancer who return to theatre to deal with complications related to the index procedure (within 30 days of surgery).
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Hospital Inpatient
- Professionals Involved In the Delivery of Service
Colorectal cancer: proportion of patients with rectal cancer who undergo elective surgical resection following neo-adjuvant long course radiotherapy or chemoradiotherapy in which the circumferential margin is clear of tumour.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Hospital Inpatient
- Professionals Involved In the Delivery of Service
Colorectal cancer: proportion of patients with rectal cancer who undergo elective primary surgical resection or surgical resection following short course neo-adjuvant radiotherapy in which the circumferential margin is clear of tumour.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Hospital Inpatient
- Professionals Involved In the Delivery of Service
Colorectal cancer: proportion of patients with rectal cancer with threatened or involved circumferential resection margin (CRM) on pre-operative MRI who receive long course neo-adjuvant chemoradiotherapy.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory/Office-based Care, Ambulatory Procedure/Imaging Center, Hospital Inpatient, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Colorectal cancer: proportion of patients with colorectal cancer who undergo curative surgical resection where greater than or equal to 12 lymph nodes are pathologically examined.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Hospital Inpatient
- Professionals Involved In the Delivery of Service
Colorectal cancer: proportion of patients with colorectal cancer who undergo elective surgical resection which involves stoma creation who are seen and have their stoma site marked pre-operatively by a nurse with expertise in stoma care.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Hospital Inpatient
- Professionals Involved In the Delivery of Service
Colorectal cancer: proportion of patients with colorectal cancer who are discussed at a multidisciplinary team (MDT) meeting before definitive treatment.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory/Office-based Care, Ambulatory Procedure/Imaging Center, Hospital Inpatient, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Colorectal cancer: proportion of patients with colorectal cancer who undergo elective surgical resection who have the whole colon visualised by colonoscopy or CT colonography before surgery, unless the non-visualised segment of colon is to be removed.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory/Office-based Care, Ambulatory Procedure/Imaging Center, Hospital Inpatient, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Colorectal cancer: proportion of patients with rectal cancer undergoing definitive treatment (chemoradiotherapy or surgical resection) who undergo CT chest, abdomen and pelvis and MRI pelvis before definitive treatment.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory/Office-based Care, Ambulatory Procedure/Imaging Center, Hospital Inpatient, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Cutaneous melanoma: proportion of patients with cutaneous melanoma undergoing groin block dissection who have been referred to a lymphoedema service.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Hospital Inpatient, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Cutaneous melanoma: proportion of patients with stage III and IV cutaneous melanoma who undergo CT or positron emission tomography (PET) CT prior to completion lymphadenectomy.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory Procedure/Imaging Center, Hospital Inpatient, Hospital Outpatient
- Professionals Involved In the Delivery of Service